Press Release, EIN Presswire Örn Almarsson 5/28/19 Press Release, EIN Presswire Örn Almarsson 5/28/19 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ December 16, 2025 Read More Press Release, EIN Presswire Örn Almarsson 5/28/19 Press Release, EIN Presswire Örn Almarsson 5/28/19 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ December 19, 2025 Read More Media, Interview Örn Almarsson 5/28/19 Media, Interview Örn Almarsson 5/28/19 'Developing and delivering mRNA lipid nanoparticle therapeutics’ - BioTechniques Interview with Örn May 27, 2025 Read More Media, Interview Örn Almarsson 5/28/19 Media, Interview Örn Almarsson 5/28/19 Örn Almarsson interviewed by Lucia Donajová from Synthace March 28, 2025 Read More View All News
Press Release, EIN Presswire Örn Almarsson 5/28/19 Press Release, EIN Presswire Örn Almarsson 5/28/19 ‘Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board’ December 16, 2025 Read More
Press Release, EIN Presswire Örn Almarsson 5/28/19 Press Release, EIN Presswire Örn Almarsson 5/28/19 ‘Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics’ December 19, 2025 Read More
Media, Interview Örn Almarsson 5/28/19 Media, Interview Örn Almarsson 5/28/19 'Developing and delivering mRNA lipid nanoparticle therapeutics’ - BioTechniques Interview with Örn May 27, 2025 Read More
Media, Interview Örn Almarsson 5/28/19 Media, Interview Örn Almarsson 5/28/19 Örn Almarsson interviewed by Lucia Donajová from Synthace March 28, 2025 Read More
